Drug intelligence / Profile preview

equine tetanus immunoglobulin

Development stage
Unknown
Lead developer
Yuxi Jiuzhou Biotechnology
Modality
Antibody-Based Therapeutics
Administration
Intramuscular
01

Overview

Equine tetanus immunoglobulin (F(ab')2) is a biological preparation containing specific antibodies (antitoxins) derived from the plasma of horses immunized against tetanus toxin. The product is processed through enzymatic digestion to yield F(ab')2 fragments, which retain the ability to neutralize the tetanus toxin (tetanospasmin) produced by *Clostridium tetani* while reducing the risk of hypersensitivity reactions and serum sickness compared to whole-molecule equine IgG. Developed by Yuxi Jiuzhou Biotechnology, it is primarily indicated for providing immediate, short-term passive immunity for the prevention and treatment of tetanus infection, particularly in cases where human tetanus immunoglobulin is unavailable.

Other names
tetanus antitoxin (equine)equine tetanus immunoglobulin (F(ab')2)tetanus immunoglobulin (equine)

Beyond the preview

Go deeper on equine tetanus immunoglobulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on equine tetanus immunoglobulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call